HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$4.09
Day range
$4.00 - $4.18
Year range
$0.36 - $6.04
Market cap
394.38M USD
Avg Volume
562.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 18.05M | -4.94% |
Operating expense | 49.16M | 61.20% |
Net income | -46.61M | 21.57% |
Net profit margin | -258.16 | 17.49% |
Earnings per share | — | — |
EBITDA | -33.28M | 35.13% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 234.28M | -24.56% |
Total assets | 307.97M | -34.15% |
Total liabilities | 502.42M | 16.84% |
Total equity | -194.45M | — |
Shares outstanding | 82.81M | — |
Price to book | -1.74 | — |
Return on assets | -25.36% | — |
Return on capital | -80.74% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -46.61M | 21.57% |
Cash from operations | -44.10M | -198.52% |
Cash from investing | -531.00K | 47.74% |
Cash from financing | 356.00K | 281.63% |
Net change in cash | -44.31M | -178.80% |
Free cash flow | -29.45M | -928.88% |
About
Founded
2011
Website
Employees
274